Arcadia Biosciences annual meeting: say-on-pay passes narrowly; directors elected with ~55% support

Arcadia Biosciences, Inc.

Approximately 51% of outstanding shares (703,677) were present at Dec 19, 2025 annual meeting.
Directors Bolles, Comcowich, Schaefer elected with ~79,500 FOR vs ~64,300 WITHHELD (55% of votes cast).
Advisory 'say-on-pay' vote passed 72,445 FOR vs 70,865 AGAINST, a margin of only 1,580 votes.
Ratification of Deloitte & Touche as auditor approved with 697,730 FOR, 4,574 AGAINST, 1,372 ABSTAIN.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.